New coronavirus disease (COVID-19) and kidney injury

doi:10.3877/cma.j.issn.2095-3216.2020.03.008

Abstract

Abstract:

Since its discovery in China in December 2019, the new coronavirus disease (COVID-19) has now broken out in 213 countries around the world, affecting more than 5.4 million people and causing the death of nearly 350, 000 people. WHO has defined it as a global pandemic. In addition to respiratory system involvement, COVID-19 was also accompanied by other organs injuries, especially in severely ill patients, some of whom showed kidney damage manifesting as hematuria, proteinuria, and increased levels of blood urea nitrogen or serum creatinine. The incidence of acute kidney injury in critically ill patients was high and it affected their prognosis. This article reviewed the epidemiology, clinical features, pathogenesis, pathological manifestations, treatment, and prognosis of kidney injury in COVID-19 patients, hoping to provide relevant information for the prevention and control of COVID-19 from the perspective of nephrology.

Key words: COVID-19, Coronavirus, Kidney injury

Guang Yang, Yang Liu, Jiahui Zhao, Qingli Cheng. New coronavirus disease (COVID-19) and kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(03): 127-130.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2020.03.008

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2020/V09/I03/127

References 28

[1]	World Health Organization. Report of the WHO－China joint mission on coronavirus disease 2019 (COVID－19) [EB/OL]. 2020: URL
[2]	中华人民共和国卫生健康委员会. 截至5月25日24时新型冠状病毒肺炎疫情最新情况[EB/OL]. 2020： URL
[3]	Rismanbaf A, Zarei S. Liver and kidney injuries in covid－19 and their effects on drug therapy, a letter to editor [J]. Arch Acad Emerg Med, 2020, 8(1): e17.
[4]	Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus－infected pneumonia [J]. N Engl J Med, 2020, 382(13): 1199-1207.
[5]	Sanche S, Lin YT, Xu C, et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2 [J]. Emerg Infect Dis, 2020, 26(7): 1470-1477.
[6]	Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus－infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
[7]	Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [J]. N Engl J Med, 2020, 382(18): 1708-1720.
[8]	Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in－hospital death of patients with COVID－19 [J]. Kidney Int, 2020, 97(5): 829-838.
[9]	Anti－2019－nCoV Volunteers, Li Z, Wu M, et al. Caution on kidney dysfunctions of covid－19 patients [J]. medRxiv, 2020, [https：// doi.org/ 10.1101/ 2020. 02. 08.20021212]．
[10]	Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS－CoV－2 pneumonia in Wuhan, China: a single－centered, retrospective, observational study [J]. Lancet Respir Med, 2020, 8 (5): 475-481.
[11]	Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID－19 [J]. Kidney Int, 2020, 98(1): 209-218.
[12]	Wang L, Li X, Chen H, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China [J]. Am J Nephrol, 2020, 51(5): 343-348.
[13]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
[14]	Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223): 507-513.
[15]	Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [J]. JAMA Intern Med, 2020，[published online ahead of print].
[16]	Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID－19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med, 2020, 8(4): 420-422.
[17]	姚小红，李廷源，何志承，等．新型冠状病毒肺炎(COVID－19)三例遗体多部位穿刺组织病理学研究 [J]. 中华病理学杂志，2020, 49(05): 411-417.
[18]	Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J]. Nature, 2020, 579(7798): 270-273.
[19]	Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J]. Lancet, 2020, 395(10224): 565-574.
[20]	Hoffmann M, Kleine－Weber H, Krüger N, et al. The novel coronavirus 2019 (2019－nCoV) uses the SARS－coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells [J]. bioRxiv, 2020, [https：//doi.org/10.1101/2020.01.31.929042]．
[21]	Zou X, Chen K, Zou J, et al. Single－cell RNA－seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019－nCoV infection [J]. Front Med, 2020, 14 (2): 185-192.
[22]	Pan XW, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID－19 outbreak: a study based on single－cell transcriptome analysis [J]. Intensive Care Med, 2020, 46(6): 1114-1116.
[23]	Ronco C, Reis T. Kidney involvement in COVID－19 and rationale for extracorporeal therapies [J]. Nat Rev Nephrol, 2020, 16(6): 308-310.
[24]	Chena G, Zhou YZ, Ma J, et al. Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID－19 patients? [J]. Ren Fail, 2020, 42(1): 483-488.
[25]	Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID－19 associated pneumonia in clinical studies [J]. Biosci Trends, 2020, 14(1): 72-73.
[26]	Yang Y, Shi J, Ge S, et al. Effect of continuous renal replacement therapy on all－cause mortality in COVID－19 patients undergoing invasive mechanical ventilation: a retrospective cohort study [J]. medRxiv, 2020, [https：// doi.org/ 10.1101/2020.03.16.20036780]．
[27]	Liu Y, Sun W, Li J, et al. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019 [J]. medRxiv, 2020, [https：//doi.org/10.1101/2020.02.17.20024166]．
[28]	Hatem A, Daoud A, Mohamed MM, et al. Survival rate in acute kidney injury superimposed COVID－19 patients: a systematic review and meta－analysis [J]. Ren Fail, 2020, 42(1): 393-397.

Please choose a citation manager

Content to export